SCHEMBL1992679

SCHEMBL1992679

CCOC(=O)Cc1nc(Cl)cc2ccc(F)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
HPGD P15428 2/20 0.43
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HK1 P19367 1/20 0.42
HKDC1 Q2TB90 1/20 0.42
MAOB P27338 2/20 0.42
PRNP P04156 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
TSHR P16473 1/20 0.40
MAPT P10636 2/20 0.38
RECQL P46063 1/20 0.38
PTPN1 P18031 1/20 0.38
RAB9A P51151 1/20 0.38
GAA P10253 1/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2215224 0.83 ALDH1A1 (0.51) MEN1KMT2AHPGDPOLBHTT
SCHEMBL1993736 0.81 ALDH1A1 (0.48) MEN1KMT2AHPGDPOLBHTT
SCHEMBL1994461 0.81 TSHR (0.42) TSHRS1PR2
SCHEMBL1996753 0.77 AKT1 (0.43) MEN1KMT2AMAPTSLC6A4
SCHEMBL2211684 0.77 ALDH1A1 (0.45) MEN1KMT2AHPGDPOLBHTT
SCHEMBL29215958 0.75 RAB9A (0.45) KMT2AALDH1A1SMN1; SMN2TDP1MAPT
SCHEMBL14979247 0.73 SMN1; SMN2 (0.55) HTTALDH1A1SMN1; SMN2HK1HKDC1
SCHEMBL27367110 0.72 HPGD (0.56) MEN1KMT2AHPGDPOLBHTT
SCHEMBL12798449 0.72 RAB9A (0.44) MEN1KMT2AHTTALDH1A1SMN1; SMN2
SCHEMBL3742052 0.72 RAB9A (0.44) MEN1KMT2APOLBALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO MEN1 427/4885KMT2A 3648/4885HPGD 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.